Placeholder Banner

Announcing BUZZ of BIO Winners for the 2018 BIO Investor Forum

September 7, 2018
BIO is pleased to announce the winners of the 2018 BIO Investor Forum Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector. Ten pioneering biotech companies were nominated in each of three categories—Early Stage Entrepreneurs, Late Stage Leaders, and Diagnostics and Beyond. Voting closed August 30.

Locus Biosciences, a private, emerging biotechnology company, won in the Early Stage Entrepreneurs category. Locus Biosciences is developing CRISPR-engineered precision antibacterial products to address critical unmet medical needs in antibiotic-resistant bacterial infections and microbiome-related disease. Learn more about Locus Biosciences.

Garnering the most votes in the Late Stage Leaders category was Caladrius Biosciences (NASDAQ: CLBS), a clinical stage development company with cell therapy products in development based on multiple technology platforms and targeting autoimmune and select cardiology indications. The Company is investigating its lead product candidate, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of recent-onset type 1 diabetes in a currently enrolling Phase 2 trial. Learn more about Caladrius Biosciences.

In the category of Diagnostics and Beyond, QT Medical, a medical device startup, took home the grand prize. QT Medical aims to make high quality 12-lead electrocardiogram (ECG) available to everyone. QT ECG™, the first product of QT Medical, is the world's most compact 12-lead ECG system. Focusing on innovations in the field of telemedicine and home care, QT Medical invests in research and development of products that will bring better cardiac care to patients. Learn more about QT Medical.

Congratulations to the three companies! Each will receive complimentary conference registration and a company presentation.

The BIO Investor Forum will take place October 17-18 at the Westin St. Francis Hotel in San Francisco and will focus on investment opportunities for early stage and established private companies as well as emerging public companies.

Advance media registration is now available for qualified reporters working full time for print, broadcast and web publications with valid press credentials.

Visit us to learn more about the BIO Investor Forum, including registration, programming, company presentations and partnering information.